Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Pharmacology|February 21, 2022
A Regression Model to Predict Linezolid Induced Thrombocytopenia in Neonatal Sepsis Patients: A Ten-Year Retrospective Cohort StudyLufen Duan, Qin Zhou, Zongtai Feng, et al.Frontiers in Pharmacology|March 17, 2022
The Impact of a Multifaceted Pharmacist-Led Antimicrobial Stewardship Program on Antibiotic Use: Evidence From a Quasi-Experimental Study in the Department of Vascular and Interventional Radiology in a Chinese Tertiary HospitalJinhui Xu, Jian Huang, YanXia Yu, et al.BMC Health Services Research|July 19, 2023
A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in ChinaLinjun Xie, Leyun Ding, Lian Tang, et al.BMC Infectious Diseases|August 2, 2022
Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional studyJinhui Xu, Lufen Duan, Jiahui Li, et al.The Journal of Antimicrobial Chemotherapy|June 21, 2023
Establishment and validation of a risk prediction model incorporating concentrations of linezolid and its metabolite PNU142300 for linezolid-induced thrombocytopeniaJinhui Xu, Jian Lu, Yunlong Yuan, et al.Anti-Cancer Drugs|October 3, 2020
Ticagrelor prevents tumor metastasis via inhibiting cell proliferation and promoting platelet apoptosisXingjun Meng, Weisheng Liu, Hui Yang, et al.International Journal of Antimicrobial Agents|June 10, 2023
Dose optimisation of linezolid in critically ill patients based on a population pharmacokinetic model: A two-centre prospective interventional studyLu Shi, Ying Zhang, Lufen Duan, et al.Frontiers in Pharmacology|March 30, 2022
Dose Optimization of Teicoplanin for Critically Ill Patients With Renal Dysfunction and Continuous Renal Replacement Therapy: Experience From a Prospective Interventional StudyLu Shi, Zhiwei Zhuang, Lufen Duan, et al.Pageof 3